BeyondSpring Inc. Comprehensive Income
BeyondSpring Inc. (BYSI) reported Comprehensive Income of -$1.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$1.15M.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$2.40M, a 154.82% decline year-over-year.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$2.45M.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$1.65M.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$1.74M.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$10.68M.
- BeyondSpring Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$20.57M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.15M 10-Q · filed 2026-08-14 | -$3.56M 10-Q · filed 2026-08-14 | -$6.00M derived: sum of 3 quarters · filed 2026-08-14 | -$7.65M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$2.40M 10-Q · filed 2026-05-13 | -$4.85M derived: sum of 2 quarters · filed 2026-05-13 | -$6.50M derived: sum of 3 quarters · filed 2026-05-13 | -$8.52M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.09M derived: sum of 2 quarters · filed 2026-03-25 | -$6.12M derived: sum of 3 quarters · filed 2026-08-14 | -$1.74M 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$1.65M 10-Q · filed 2025-11-12 | -$3.67M derived: sum of 2 quarters · filed 2026-08-14 | $708.00K 10-Q · filed 2025-11-12 | -$364.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$2.03M 10-Q · filed 2026-08-14 | $2.35M 10-Q · filed 2026-08-14 | $1.28M derived: sum of 3 quarters · filed 2026-08-14 | -$1.43M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $4.38M 10-Q · filed 2026-05-13 | $3.31M derived: sum of 2 quarters · filed 2026-05-13 | $597.00K derived: sum of 3 quarters · filed 2026-05-13 | -$3.33M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.78M derived: sum of 2 quarters · filed 2026-03-25 | -$7.71M derived: sum of 3 quarters · filed 2026-03-25 | -$10.68M 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$2.71M 10-Q · filed 2025-11-12 | -$6.64M derived: sum of 2 quarters · filed 2025-11-12 | -$9.61M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$3.93M 10-Q · filed 2025-08-13 | -$6.90M 10-Q · filed 2025-08-13 | -$6.90K 6-K · filed 2024-08-29 | ||
| 2024-03-31 | -$2.97M 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | -$20.57M 10-K · filed 2025-03-27 | ||||
| 2023-06-30 | -$11.93K 6-K · filed 2024-08-29 | -$11.93M 6-K · filed 2024-02-02 | |||
| 2022-12-31 | -$32.32M 20-F · filed 2023-04-18 | ||||
| 2022-06-30 | -$17.85M 6-K · filed 2024-02-02 | ||||
| 2021-12-31 | -$9.64M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$28.04M derived: sum of 2 quarters · filed 2023-04-18 | -$47.47M derived: sum of 3 quarters · filed 2023-04-18 | -$64.41M 20-F · filed 2023-04-18 | |
| 2021-09-30 | -$18.40M 6-K · filed 2021-12-30 | -$37.83M derived: sum of 2 quarters · filed 2021-12-30 | -$54.77M 6-K · filed 2021-12-30 | -$72.61M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-06-30 | -$19.43M 6-K · filed 2021-09-10 | -$36.37M 6-K · filed 2023-02-28 | -$54.21M derived: sum of 3 quarters · filed 2023-04-18 | -$69.00M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-03-31 | -$16.94M 6-K · filed 2021-06-16 | -$34.78M derived: sum of 2 quarters · filed 2023-04-18 | -$49.57M derived: sum of 3 quarters · filed 2023-04-18 | -$62.32M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2020-12-31 | -$17.85M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$32.63M derived: sum of 2 quarters · filed 2023-04-18 | -$45.38M derived: sum of 3 quarters · filed 2023-04-18 | -$61.41M 20-F · filed 2023-04-18 | |
| 2020-09-30 | -$14.78M 6-K · filed 2021-12-30 | -$27.54M derived: sum of 2 quarters · filed 2021-12-30 | -$43.56M 6-K · filed 2021-12-30 | -$57.72M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-06-30 | -$12.75M 6-K · filed 2021-09-10 | -$28.78M 6-K · filed 2021-09-10 | -$42.94M derived: sum of 3 quarters · filed 2022-04-14 | -$52.16M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-03-31 | -$16.03M 6-K · filed 2021-06-16 | -$30.18M derived: sum of 2 quarters · filed 2022-04-14 | -$39.40M derived: sum of 3 quarters · filed 2022-04-14 | -$46.57M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2019-12-31 | -$14.16M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | -$23.38M derived: sum of 2 quarters · filed 2022-04-14 | -$30.54M derived: sum of 3 quarters · filed 2022-04-14 | -$37.99M 20-F · filed 2022-04-14 | |
| 2019-09-30 | -$9.22M 6-K · filed 2020-11-17 | -$16.38M derived: sum of 2 quarters · filed 2020-11-17 | -$23.83M 6-K · filed 2020-11-17 | -$37.96M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-06-30 | -$7.17M 6-K · filed 2020-09-03 | -$14.61M 6-K · filed 2020-09-03 | -$28.74M derived: sum of 3 quarters · filed 2021-04-30 | -$43.52M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-03-31 | -$7.45M 6-K · filed 2020-06-11 | -$21.58M derived: sum of 2 quarters · filed 2021-04-30 | -$36.35M derived: sum of 3 quarters · filed 2021-04-30 | -$48.34M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2018-12-31 | -$14.13M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | -$28.91M derived: sum of 2 quarters · filed 2021-04-30 | -$40.89M derived: sum of 3 quarters · filed 2021-04-30 | -$54.65M 20-F · filed 2021-04-30 | |
| 2018-09-30 | -$14.78M 6-K · filed 2019-12-18 | -$26.76M derived: sum of 2 quarters · filed 2019-12-18 | -$40.52M 6-K · filed 2019-12-18 | -$56.03M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-06-30 | -$11.99M 6-K · filed 2019-09-18 | -$25.74M 6-K · filed 2019-09-18 | -$41.25M derived: sum of 3 quarters · filed 2020-04-30 | -$56.85M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-03-31 | -$13.75M 6-K · filed 2019-07-10 | -$29.26M derived: sum of 2 quarters · filed 2020-04-30 | -$44.87M derived: sum of 3 quarters · filed 2020-04-30 | -$58.20M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2017-12-31 | -$15.51M derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -$31.11M derived: sum of 2 quarters · filed 2020-04-30 | -$44.45M derived: sum of 3 quarters · filed 2020-04-30 | -$91.85M 20-F · filed 2020-04-30 | |
| 2017-09-30 | -$15.60M 6-K · filed 2017-11-09 | -$28.94M derived: sum of 2 quarters · filed 2018-10-23 | -$76.34M 6-K · filed 2017-11-09 | -$79.90M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-06-30 | -$13.34M 6-K · filed 2018-10-23 | -$60.74M 6-K · filed 2018-10-23 | -$64.30M derived: sum of 3 quarters · filed 2019-04-30 | -$67.38M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-03-31 | -$47.40M 6-K · filed 2018-06-21 | -$50.96M derived: sum of 2 quarters · filed 2019-04-30 | -$54.04M derived: sum of 3 quarters · filed 2019-04-30 | -$57.61M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2016-12-31 | -$3.56M derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | -$6.64M derived: sum of 2 quarters · filed 2019-04-30 | -$10.21M derived: sum of 3 quarters · filed 2019-04-30 | -$12.05M 20-F · filed 2019-04-30 | |
| 2016-09-30 | -$3.08M 6-K · filed 2017-11-09 | -$6.65M derived: sum of 2 quarters · filed 2017-11-09 | -$8.49M 6-K · filed 2017-11-09 | ||
| 2016-06-30 | -$3.57M derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | -$5.41M 6-K · filed 2017-08-21 | |||
| 2016-03-31 | -$1.84M 6-K · filed 2017-05-22 | ||||
| 2015-12-31 | -$7.98M 20-F · filed 2018-04-03 | ||||
| 2014-12-31 | -$2.87M 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |